A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PAP / plasmin-antiplasmin complexes

[Related PubMed/MEDLINE]
Total Number of Papers: 139
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PAP  (>> Co-occurring Abbreviation)
Long Form:   plasmin-antiplasmin complexes
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 D-dimer corrected for thrombin and plasmin generation is a strong predictor of mortality in patients with sepsis. DD, DD
2019 Defibrotide enhances fibrinolysis in human endotoxemia - a randomized, double blind, crossover trial in healthy volunteers. LPS, PAI-1, tPA
2019 Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-alpha2-antiplasmin complex, and t-PA: PAI-1 complex. CLSI, TAT, TM, tPAI-C
2018 Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease. AA, CKD, PAI-1, tPA, uPA
2017 A case control study on the structural equation model of the mechanism of coagulation and fibrinolysis imbalance in chronic schistosomiasis. AMOS, AT, ATIII, DD, FVIII, PAI-1, PC, PLG, PS, tPA, uPA
2017 An in vitro study of the effects of t-PA and tranexamic acid on whole blood coagulation and fibrinolysis. ETP, FLEV, Ly, MA, tPA, TXA
2017 Colistin dampens fibrinolysis and endothelial activation during endotoxaemia. A randomised, double blind trial. LPS, PAI-1, TAT, tPA, vWF
2017 Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women. OCs, TAT
2016 Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin. BP, CRP, FMD, IMT, PAI-1, PCOS, PWV
10  2016 Altered Hypercoagulability Factors in Patients with Chronic Chagas Disease: Potential Biomarkers of Therapeutic Response. ETP
11  2016 Coagulation during elective neurosurgery with hydroxyethyl starch fluid therapy: an observational study with thromboelastometry, fibrinogen and factor XIII. HES, ROTEM, TAT
12  2016 Kinetics of coagulation in ST-elevation myocardial infarction following successful primary percutaneous coronary intervention. alpha2-AP, anti-Xa, APTT, CMR, LVEF, MVI, PCI, PT, STEMI, vWF
13  2016 TAVI induces an elevation of hemostasis-related biomarkers, which is not causative for post-TAVI thrombocytopenia. TAT, TAVI
14  2016 The hemostatic disturbance in patients with acute aortic dissection: A prospective observational study. DIC, ELISAs, TAT
15  2015 Effects of steroids on thrombogenic markers in patients undergoing unilateral total knee arthroplasty: a prospective, double-blind, randomized controlled trial. IL-6, TKA, VTE
16  2015 Label-Free Kinetic Studies of Hemostasis-Related Biomarkers Including D-Dimer Using Autologous Serum Transfusion. TAT
17  2015 Relationship of pericardial fat with biomarkers of inflammation and hemostasis, and cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. CRP, CVD, IL, ln
18  2014 Activation of markers of inflammation, coagulation and fibrinolysis in musculoskeletal trauma. ---
19  2014 Assessment of biomarkers and predictive model for short-term prospective abdominal aortic aneurysm growth-A pilot study. AAAs, CI, CRF, OR
20  2013 Association of novel biomarkers with future cardiovascular events is influenced by ethnicity: results from a multi-ethnic cohort. CRP, CVD, IL-6, MESA
21  2013 Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis. sc, THA
22  2013 Circulating biomarkers for abdominal aortic aneurysm: what did we learn in the last decade? 4 reviews, AAA
23  2013 Intracameral concentrations of the fibrinolytic system components in patients with age-related macular degeneration. AMD
24  2013 Long-term treatment with ramipril favourably modifies the haemostatic response to acute submaximal exercise in hypertensives. DD, sP-sel, sTM, TAT, vWF
25  2013 Obesity in haemophilia patients: effect on bleeding frequency, clotting factor concentrate usage, and haemostatic and fibrinolytic parameters. BMI, CFC, PWH, VWF
26  2013 Study on related indexes of the coagulation and fibrinolytic system after renal ischemia reperfusion injury in Wistar rats. ATIII, FIB, IR, PAI-1, tPA
27  2012 Vascular endothelial growth factor and uPA/suPAR system in early and advanced chronic kidney disease patients: a new link between angiogenesis and hyperfibrinolysis? CKD, PAI-1, TF, tPA, uPA, VEGF
28  2011 Coagulation activation and fibrinolysis impairment are reduced in patients with anxiety and depression when medicated with serotonergic antidepressants. ---
29  2011 Diabetes does not influence activation of coagulation, fibrinolysis or anticoagulant pathways in Gram-negative sepsis (melioidosis). TAT
30  2011 Kidney function and multiple hemostatic markers: cross sectional associations in the multi-ethnic study of atherosclerosis. CKD, eGFR, MESA, PAI-1, sTF, sTM, TFPI, vWF
31  2011 The effect of cause of cadaveric kidney donors death on fibrinolysis and blood coagulation processes. AT, CNS, ID, KD, ND, PL, PPV, TAT
32  2010 Circulating hepatocyte growth factor as an independent prognostic factor of disseminated intravascular coagulation. DIC, HGF, IL, TAT
33  2010 Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab. EMPs, PNH, sTM, TFPI, tPA
34  2010 Treatment related changes in antifibrinolytic activity in patients with polycythemia vera. 5-HU, PAI-1, PV, TAFIa, TM
35  2010 [Change of coagulation and fibrinolysis in rabbit model with acute decompression sickness and its mechanism]. APTT, DCS, FDP, FIB, FPA, PAI-1, PT, TM, TT
36  2009 Effect of ACE inhibition on the fibrinolytic system in patients requiring coronary artery bypass grafting. CABG, PAI-1, tPA
37  2009 Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. sGPV, TAT, TF-MP
38  2009 Thrombosis markers in hip versus knee arthroplasty: a pilot study. THA, TKA
39  2008 Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients. HD, PAI-1, PVH, SOX, TF, tPA, uPA
40  2008 Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with essential arterial hypertension. ACEI, TAFI, TM, vWF
41  2008 Visfatin and apelin, new adipocytokines, and their relation to endothelial function in patients with chronic renal failure. PAI-1, TAT, VCAM
42  2008 [The influence of simvastatin on hsCRP and some paramneters of hemostasis in patients with ischemic heart disease]. TAFI, TAT, TM
43  2007 Association of pulse pressure with fibrinolysis in patients with type 2 diabetes. TAT
44  2007 Elevated resistin is related to inflammation and residual renal function in haemodialysed patients. HD, hs-CRP, ICAM, IL-6, TAT, vWF
45  2007 Instability mechanisms in unstable angina according to baseline serum levels of C-reactive protein: the role of thrombosis, fibrinolysis and atherosclerotic burden. CRP, TAT
46  2007 [Haemostatic disturbances in essential thrombocythosis]. alpha2-AP, APTT, AT, ELT, ET, FDP, PAI-1, PT, TAT
47  2007 [Hemostatic disturbances in chronic myeloid leukemia]. alpha2-AP, APTT, AT, CML, ELT, FDP, PAI-1, PT, TAT
48  2006 Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation. APTT, FPA, hs-CRP, MI, TAT, VF
49  2006 Plasma level of IL-6 and its relationship to procoagulant and fibrinolytic markers in acute ischemic stroke. IL-6, PAI-1, TAT
50  2006 The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study. CPB
51  2006 Thrombin activatable fibrinolysis inhibitor in hypertensive kidney transplant recipients. ECLT, FAI, MMF, TAFI, TM
52  2005 Activation of coagulation and hyperfibrinolysis in patients with aortic arch atheromatosis (Aortic AA) as a risk factor for cerebral ischemia. Aortic AA, TAT
53  2005 Metabolic syndrome accompanied by hypercholesterolemia is strongly associated with proinflammatory state and impairment of fibrinolysis in patients with type 2 diabetes: synergistic effects of plasminogen activator inhibitor-1 and thrombin-activatable fibrinolysis inhibitor. HC, hs-CRP, MS, PAI, TAFI
54  2005 Renal transplant recipients with coronary artery disease exhibit impairment in fibrinolysis and structural changes in carotid arteries. BMI, CAD, CVD, IMT, TAFI
55  2004 Activation of blood coagulation in patients undergoing postoperative blood salvage and re-infusion of unwashed whole blood after total knee arthroplasty. TAT
56  2004 Coagulation and inflammation in overt diabetic nephropathy: association with hyperhomocysteinemia. Ccr, IL, tHcy
57  2004 Comparison of a Duraflo II-coated cardiopulmonary bypass circuit and a trillium-coated oxygenator during open-heart surgery. BTG, CPB, MPO, TAT, TCC
58  2004 Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. LDL-C, P-sel, TAFI, tPA, VO, vWF
59  2004 Foodstate vitamin C complex may beneficially affect haemostasis and fibrin network structure in hyperlipidaemic patients. TAT
60  2004 The role of intrinsic fibrinolytic system activation in pathogenesis of hemostasis disturbances in hemodialyzed patients with chronic renal failure. C1-INH, ELT, FDP, HD, PK
61  2004 [Activation of fibrynolysis in children with chronic B or C hepatitis]. PAI-1, tPA
62  2004 [Clinical study of hemostatic coagulation markers in prethrombosis state of pregnancy induced hypertension]. AT, DD, PIH
63  2004 [Clinical study of hemostatic molecular markers expression in patients with cancer]. TAT, TF, tPA, uPA, uPAR
64  2004 [Thrombophilic syndrome associated to phenotypic resistance to activated protein C in postmenopausal women]. APC-SR, HRT, PC, PS, TFPI, VTE
65  2003 Blood coagulation and fibrinolysis after long-duration treadmill exercise controlled by individual anaerobic threshold. ETP, IAT, PAI-1-AG and PAI-1-ACT, TAT, TR
66  2003 Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. OHSS, TAT, TF, TFPI, vWF
67  2003 Tissue plasminogen activator plasma levels as a potential diagnostic aid in acute pulmonary embolism. PAI-1, PE, tPA
68  2003 Von Willebrand factor in Italian centenarians. vWF, VWF, VWF
69  2003 [Plasmin-alpha 2-antiplasmin complexes in blood of patient with lichen planus against the background of other fibrinolysis parameters]. tPA
70  2002 A comprehensive study on hemostasis in CAPD patients treated with erythropoietin. CAPD, ECLT, EPO, TAFI, TAT, TF, TFPI
71  2002 Absence of paradoxical thrombin activation by fibrin-specific thrombolytics in acute myocardial infarction: comparison of single-bolus tenecteplase and front-loaded alteplase. ATIII, DD, FXIIa, KK, TAT, tPA
72  2002 Dyslipidemias and fibrinolysis. PAI, TAFI
73  2002 Impaired fibrinolytic compensation for hypercoagulability in obese patients with type 2 diabetes: association with increased plasminogen activator inhibitor-1. BMI, PAI
74  2002 Plasmin/alpha2-antiplasmin complexes (PAP) in lung cancer patients: effects of radiotherapy. ---
75  2002 The influence of low molecular weight heparin on the intravascular activation of the coagulation system in patients with acute leukemia during induction chemotherapy--report of a prospective randomized study. AL, DD, DIC, TAT
76  2002 [Diagnostic value of hemostasis activation markers in acute deep vein thrombosis]. DVT, TAT
77  2002 [Evaluation of selected parameters of blood coagulation and the fibrinolysis system in patients undergoing total hip replacement]. DD, TAT
78  2001 A possible role of thrombin-activatable fibrinolysis inhibitor in disturbances of fibrinolytic system in renal transplant recipients. CVD, RTR, sTM, TAFI, TAT
79  2001 Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. DHF, TAFI, TAT
80  2001 Changes in the extrinsic and intrinsic coagulation pathways in humans after decompression following saturation diving. ---
81  2001 Different mechanisms of fibrinolysis impairment among dyslipidemic subjects. HDL, LDL, PAI-1, TAFI
82  2001 Hemostatic and fibrinolytic parameters in survivors of myocardial infarction: a low plasma level of plasmin-alpha2-antiplasmin complex is an independent predictor of coronary re-events. CAD, MI
83  2001 Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. AOPP, CRF, FgDP, FnDP, sTM, TAT
84  2001 Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. TAT
85  2001 Thrombogenesis in sickle cell disease. beta-TG, PF4, SCD, TAT
86  2001 When should heparin preferably be administered during radiofrequency catheter ablation? beta-TG
87  2001 [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia]. ATRA, TAT, TF, TFPI, uPA, uPAR
88  2000 Fibrinolysis system in patients with bronchial asthma. ELT, FDP, PAI-1, t-PA Ag, u-PA Ag
89  2000 Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes. CML, ELT, ET, FDP, MF, MPS
90  2000 Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes. TM
91  1999 Age related elevation of serum macrophage colony stimulating factor (M-CSF) level. M-CSF, TAT, TM, vWF
92  1999 Assessment of coagulation disorders in patients with acute leukemia before and after cytostatic treatment. DD, TAT
93  1999 Consequences of acute normovolaemic haemodilution on haemostasis during major orthopaedic surgery. APTT, DD, NHD, PT, TAT
94  1999 Endothelial cell and hemostatic activation in relation to cytokines in patients with sepsis. IL-6, PAI-1, TAT, TM, tPA, vWF
95  1999 Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. PAI-1
96  1999 In vitro fertilization. Do short-term changes in estrogen levels produce increased fibrinolysis? IVF, TAT
97  1999 Intraperitoneal hypercoagulation and hypofibrinolysis is present in childhood peritonitis. DD, PAI-1, TAT, tPA
98  1999 Plasma proteolytic activity in liver transplant rejection. AP, AR, AST, KK, KKI, OLT, PKK, PL, PLG, PTH
99  1999 Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators. AF, PAPln
100  1999 Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women. AAI, IRS